E-LIB Suche - Ergebnisse für: Eide, Christopher A.

1

Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resis..:

Modak, Rucha V. ; de Oliveira Rebola, Katia G. ; McClatchy, John...
Clinical Cancer Research. 30 (2024) 10 - p. 2245-2259 , 2024

Link: https://doi.org/10.1158/..

2

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progres..:

Gonzalez, Mayra A. ; Olivas, Idaly M. ; Bencomo‐Alvarez, Alfonso E....
Clinical and Translational Medicine. 12 (2022) 12 - p. , 2022

Link: https://doi.org/10.1002/..

3

Associating drug sensitivity with differentiation status id..:

Kurtz, Stephen E. ; Eide, Christopher A. ; Kaempf, Andy...
Blood Advances. 6 (2022) 10 - p. 3062-3067 , 2022

Link: https://doi.org/10.1182/..

4

Secondary fusion proteins as a mechanism of BCR::ABL1 kinas..:

Barnes, Evan J. ; Eide, Christopher A. ; Kaempf, Andy...
British Journal of Haematology. 200 (2022) 3 - p. 323-328 , 2022

Link: https://doi.org/10.1111/..

5

Integrative analysis of drug response and clinical outcome ..:

Bottomly, Daniel ; Long, Nicola ; Schultz, Anna Reister...
Cancer Cell. 40 (2022) 8 - p. 850-864.e9 , 2022

Link: https://doi.org/10.1016/..

6

Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3)..:

Bencomo-Alvarez, Alfonso E. ; Rubio, Andres J. ; Olivas, Idaly M....
Oncogene. 40 (2021) 15 - p. 2697-2710 , 2021

Link: https://doi.org/10.1038/..

7

NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic e..:

Scopim-Ribeiro, Renata ; Machado-Neto, João Agostinho ; Eide, Christopher A....
Investigational New Drugs. 39 (2021) 3 - p. 736-746 , 2021

Link: https://doi.org/10.1007/..

8

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutat..:

Yenerall, Paul ; Kollipara, Rahul K. ; Avila, Kimberley...
Cancer Research. 81 (2021) 18 - p. 4685-4695 , 2021

Link: https://doi.org/10.1158/..

9

Aurora A kinase as a target for therapy in TCF3-HLF rearran..:

Leonard, Jessica ; Wolf, Joelle SJ ; Degnin, Michelle...
Haematologica. 106 (2021) 11 - p. 2990-2994 , 2021

Link: https://doi.org/10.3324/..

10

Simultaneous kinase inhibition with ibrutinib and BCL2 inhi..:

Eide, Christopher A. ; Kurtz, Stephen E. ; Kaempf, Andy...
Leukemia. 34 (2020) 9 - p. 2342-2353 , 2020

Link: https://doi.org/10.1038/..

11

NT157 has antineoplastic effects and inhibits IRS1/2 and ST..:

Fenerich, Bruna Alves ; Fernandes, Jaqueline Cristina ; Rodrigues Alves, Ana Paula Nunes...
Signal Transduction and Targeted Therapy. 5 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

12

A genome-wide CRISPR screen identifies regulators of MAPK a..:

Damnernsawad, Alisa ; Bottomly, Daniel ; Kurtz, Stephen E....
Haematologica. 107 (2020) 1 - p. 77-85 , 2020

Link: https://doi.org/10.3324/..

13

ERBB2/HER2 mutations are transforming and therapeutically t..:

Joshi, Sunil K. ; Keck, Jamie M. ; Eide, Christopher A....
Leukemia. 34 (2020) 10 - p. 2798-2804 , 2020

Link: https://doi.org/10.1038/..

14

Clinical resistance to crenolanib in acute myeloid leukemia..:

Zhang, Haijiao ; Savage, Samantha ; Schultz, Anna Reister...
Nature Communications. 10 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

15

Differentiation of leukemic blasts is not completely blocke..:

Agarwal, Anupriya ; Bolosky, William J. ; Wilson, David B....
Proceedings of the National Academy of Sciences of the United States of America. 116 (2019) 49 - p. 24593-24599 , 2019

Link: https://www.jstor.org/st..